Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Malissa Wood, MD. explains why Mass General created a program to combat racism and health equity.

Why health equity is important in cardiology

Malissa Wood, MD, associate chief of cardiology for diversity and equity at Massachusetts General Hospital, explains the role of health equity in cardiovascular care and what her health system is doing to address it. 

Medical student artificial intelligence training

Medical educators encouraged to equip physicians-to-be with 4 AI competencies

Researchers at the University of Illinois Chicago have developed an elective course that can quickly transform fourth-year medical students from functional AI novices to budding AI experts.

Thumbnail

Novo Nordisk close to acquiring French medical device company for $165M

The two companies first started collaborating on diabetes technology in 2021. The acquisition is not yet final, but Novo Nordisk now holds the exclusive negotiation rights.

Medicare money payment

Nearing a ‘breaking point’: Cardiologists support legislation designed to mitigate Medicare cuts to office-based services

These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 

Sam Jones, MD, explains why CMS reduced payments for EP ablation and how it will negatively impact electrophysiology. #HRS #HRS2023 #EPeeps #EPlab #Medicare

Making sense of the huge Medicare reimbursement cuts in electrophysiology

Samuel Jones, MD, examines the large reimbursement reductions in cardiac ablations and what the impact might be on access to care in EP labs.

Medtronic acquires insulin patch manufacturer for $738M

The deal represents a significant step forward for Medtronic's diabetes portfolio.

Artificial intelligence (AI) analysis from a remote ECG monitor showing the AI generated report on the Philips Cardiologs system, during a demonstration of the technology at Heart Rhythm 2023. Photo by Dave Fornell

AI correctly IDs ventricular arrhythmias in 88% of patients with sustained VT

New research suggests AI could offer physicians a new, state-of-the-art approach to sudden cardiac arrest risk management.

The proliferation of artificial intelligence (AI) in healthcare includes numerous algorithms for electrophysiology (EP). Jagmeet Singh, MD, Professor of Medicine, Harvard Medical School, and founding director of the Resynchronization and Advanced Cardiac Therapeutics Program and Mass General Hospital, spoke with Cardiovascular Business at Heart Rhythm 2023 to explain how AI is being used in EP. #HRS2023 #HRS #AI

AI gaining popularity in electrophysiology

There are now numerous AI algorithms for electrophysiology. Jagmeet Singh, MD, examined how this advanced technology is being applied.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.